- ISIN
- US2074101013
- CUSIP
- 207410101
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Jul 23, 1987
Highlights
- Market Cap
- $996.41M
- Enterprise Value
- $996.41M
- EPS (TTM)
- $1.77
- PE Ratio
- 18.36
- PEG Ratio
- 0.13
- Total Revenue (TTM)
- $1.37B
- Gross Profit (TTM)
- $756.17M
- EBITDA (TTM)
- $188.54M
- Year Range
- $31.44 - $56.64
- Target Price
- $78.00
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CNMD Performance Chart
CONMED Corporation (CNMD) is down 19.9% since the beginning of the year. At $33 per share, CNMD is trading 42.5% below its 52-week high of $57. Investors who bought $1,000 worth of CNMD shares 5 years ago would now be looking at an investment worth $238.
Loading charts...
Returns By Period
CONMED Corporation (CNMD) has returned -19.85% so far this year and -37.41% over the past 12 months. Over the last ten years, CNMD has returned -2.05% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
CONMED Corporation
- 1D
- -0.12%
- 1M
- -12.60%
- YTD
- -19.85%
- 6M
- -18.73%
- 1Y
- -37.41%
- 3Y*
- -36.77%
- 5Y*
- -24.93%
- 10Y*
- -2.05%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
CNMD Monthly Returns History
Based on dividend-adjusted daily data since Mar 26, 1990, CNMD's average daily return is +0.08%, while the average monthly return is +1.48%. At this rate, an investment would double in approximately 3.9 years.
Historically, 56% of months were positive and 44% were negative. The best month was Nov 1990 with a return of +60.0%, while the worst month was Jul 2000 at -48.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.
On a daily basis, CNMD closed higher 48% of trading days. The best single day was Mar 24, 2020 with a return of +21.8%, while the worst single day was Oct 9, 1992 at -47.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.44% | 19.82% | -23.13% | 3.68% | -2.62% | -8.85% | -19.85% | ||||||
| 2025 | 4.88% | -17.57% | 2.41% | -18.68% | 15.56% | -7.89% | -1.79% | 6.28% | -13.16% | -6.44% | -1.32% | -6.49% | -40.03% |
| 2024 | -12.70% | -15.98% | -0.07% | -15.11% | 12.44% | -9.06% | -0.40% | 6.05% | -1.51% | -5.12% | 8.50% | -7.30% | -36.84% |
| 2023 | 8.03% | 0.45% | 8.21% | 20.90% | -3.40% | 12.20% | -10.92% | -7.92% | -9.35% | -3.36% | 10.07% | 2.27% | 24.45% |
| 2022 | -2.95% | 6.24% | 1.78% | -10.49% | -12.54% | -17.48% | 1.95% | -9.28% | -9.29% | -0.55% | 3.91% | 7.22% | -36.98% |
| 2021 | -0.09% | 9.97% | 6.29% | 7.93% | -2.31% | -0.04% | 0.37% | -4.78% | -0.23% | 11.81% | -10.13% | 7.99% | 27.35% |
Benchmark Metrics
CONMED Corporation has an annualized alpha of 12.72%, beta of 0.86, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since March 26, 1990.
- This stock captured 109.60% of S&P 500 Index gains and 103.21% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 12.72%
- Beta
- 0.86
- R²
- 0.11
- Upside Capture
- 109.60%
- Downside Capture
- 103.21%
Return for Risk
Risk / Return Rank
CNMD ranks 7 for risk / return — in the bottom 7% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for CONMED Corporation (CNMD) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CNMD | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.96 | ||
| Sortino ratioReturn per unit of downside risk | -4.03 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.37 | -0.51 |
| Calmar ratioReturn relative to maximum drawdown | -0.89 | 2.78 | -3.67 |
| Martin ratioReturn relative to average drawdown | -1.53 | 12.44 | -13.97 |
Dividends
Dividend History
CONMED Corporation provided a 0.61% dividend yield over the last twelve months, with an annual payout of $0.20 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.20 | $0.60 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 |
Dividend yield | 0.61% | 1.48% | 1.17% | 0.73% | 0.90% | 0.56% | 0.71% | 0.72% | 1.25% | 1.57% | 1.81% | 1.82% |
Monthly Dividends
The table displays the monthly dividend distributions for CONMED Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.00 | $0.60 |
| 2024 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.80 |
| 2023 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.80 |
| 2022 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.80 |
| 2021 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.80 |
Dividend Yield & Payout
Dividend Yield
CONMED Corporation has a dividend yield of 0.61%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
CONMED Corporation has a payout ratio of 33.85%, which is quite average when compared to the overall market. This suggests that CONMED Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the CONMED Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CONMED Corporation was 78.76%, occurring on Jun 17, 2026. The portfolio has not yet recovered.
The current CONMED Corporation drawdown is 78.47%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -78.76%Jun 2026 | 4y 7mo | — | 4y 7moNov 2021 - now |
1992 bear market1992 | -76.46%Oct 1992 | 7mo 29d | 2y 9mo | 3y 5moFeb 1992 - Jul 1995 |
COVID crash2020 | -65.68%Mar 2020 | 3mo 28d | 9mo 19d | 1y 1moNov 2019 - Jan 2021 |
Financial crisis2007–2009 | -64.60%Mar 2009 | 5mo 18d | 4y 6d | 4y 5moSep 2008 - Mar 2013 |
Dot-com crash2000–2002 | -64.58%Aug 2000 | 1y 2mo | 1y 6mo | 2y 9moJun 1999 - Mar 2002 |
Drawdown Indicators
| CNMD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.76% | -56.78% | -21.98% |
Max Drawdown (1Y)Largest decline over 1 year | -42.25% | -9.10% | -33.15% |
Max Drawdown (3Y)Largest decline over 3 years | -75.85% | -18.90% | -56.95% |
Max Drawdown (5Y)Largest decline over 5 years | -78.76% | -25.43% | -53.33% |
Max Drawdown (10Y)Largest decline over 10 years | -78.76% | -33.92% | -44.84% |
Current DrawdownCurrent decline from peak | -78.47% | -1.80% | -76.67% |
Average DrawdownAverage peak-to-trough decline | -26.43% | -10.71% | -15.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.41% | 2.03% | +22.38% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of CONMED Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how CONMED Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CNMD, comparing it with other companies in the Medical Devices industry. Currently, CNMD has a P/E ratio of 18.4. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CNMD compared to other companies in the Medical Devices industry. CNMD currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CNMD relative to other companies in the Medical Devices industry. Currently, CNMD has a P/S ratio of 0.7. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CNMD
Add CONMED Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CNMD